Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

220
Delayed Quote. Delayed CHI-X EUROPE LIMITED. - 03/03 04:59:57 pm
315.5000 DKK   -0.63%
03/02 NOVO NORDISK A/ : A/S: A/S - Share repurchase programme
03/02DJNovo Increases Price Range For its IT Services' IPO
02/26 NOVO NORDISK A/ : receives Health Canada approval for Saxenda® (lira..
SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVO NORDISK A/S
03/02 NOVO NORDISK A/S : A/S: A/S - Share repurchase programme
03/02DJNovo Increases Price Range For its IT Services' IPO
02/26 NOVO NORDISK A/S : receives Health Canada approval for Saxenda® (liraglutide) fo..
02/25DJSanofi Wins Approval For New Insulin Drug
02/25DJSanofi Wins Approval For New Insulin Drug
02/24 NOVO NORDISK A/S : sets indicative price range for the contemplated IPO of NNIT ..
02/23 NOVO NORDISK A/S : BRIEF: Diabetes group to meet
02/23 NOVO NORDISK A/S : A/S : - Share repurchase programme
02/23DJNOVO NORDISK A/S : Sets IT Unit IPO Price at DKK100-DKK120
02/23 NOVO NORDISK A/S : Notice for the Annual General Meeting of Novo Nordisk A/S; An..
02/20 NOVO NORDISK A/S : announces positive results for phase 2 trial with oral semagl..
02/20 NOVO NORDISK A/S : Trademark Application for "SEMLIFCA" Filed
02/20 NOVO NORDISK A/S : An Application for the Trademark "ZEMLOYA" Has Been Filed by ..
02/20 Notice for the Annual General Meeting of Novo Nordisk A/S
02/20 NOVO NORDISK A/S : Notice for the Annual General Meeting of Novo Nordisk A/S
02/20 NOVO NORDISK A/S : Trademark Application for "GREDUZY" Filed
02/19 NOVO NORDISK A/S : An Application for the Trademark "OZEMPIC" Has Been Filed by ..
02/19 NOVO NORDISK A/S : International GPCR Consortium Announces Addition of New Membe..
02/19 NOVO NORDISK A/S : Trademark Application for "BESQW" Filed by Novo Nordisk A/S
02/19 NOVO NORDISK A/S : Trademark Application for "OSEMPIC" Filed by Novo Nordisk A/S
02/19 NOVO NORDISK A/S : "GLP-1 Agonists" in Patent Application Approval Process
02/19 NOVO NORDISK A/S : An Application for the Trademark "CIVOVIC" Has Been Filed by ..
02/19 NOVO NORDISK A/S : Trademark Application for "VUDECRI" Filed by Novo Nordisk A/S
02/16 NOVO NORDISK A/S : Changes to the Supervisory Board of Carlsberg A/S
02/16 NOVO NORDISK A/S : A/S : - Share repurchase programme
02/12 NOVO NORDISK A/S : Sweden, Denmark to collaborate on diabetes research
02/11 NOVO NORDISK A/S : Karolinska Institutet partner for diabetes research program
02/11 NOVO NORDISK A/S : and Karolinska Institutet join forces in the field of diabete..
02/11 NOVO NORDISK A/S : and Karolinska Institutet join forces in the field of diabete..
02/10 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/10 NOVO NORDISK A/S : Share repurchase programme
02/09 NOVO NORDISK A/S : A/S: Trading in shares by board members, executives and assoc..
02/09 NOVO NORDISK A/S : A/S : A/S - Share repurchase programme
02/09DJNOVO NORDISK A/S : Seeks Copenhagen IPO of IT Services Unit NNIT
02/06 NOVO NORDISK A/S : A/S: Trading in shares by board members, executives and assoc..
02/05 NOVO NORDISK A/S : files annual report with the SEC
02/04 NOVO NORDISK A/S : "Subtilase Variants" in Patent Application Approval Process
02/04 NOVO NORDISK A/S : Patent Application Titled "Automatic Injection Device with Re..
02/04 NOVO NORDISK A/S : ‘racing to change diabetes'
02/04 NOVO NORDISK A/S : Danish central bank should keep euro peg, says CEO of Novo No..
02/04 NOVO NORDISK A/S : Findings on Hemophilia Reported by Investigators at Novo Nord..
02/04 NOVO NORDISK A/S : A diabetic … and an inspiration
02/03 NOVO NORDISK A/S : Publishes 2014 integrated Annual Report Emphasising Long-Term..
02/03 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/02 NOVO NORDISK A/S : Victory a boost to advocacy vs disease: 'Diabetic' Kiwi rules..
02/02 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
02/02 NOVO NORDISK A/S : increased operating profit in local currencies by 13% in 2014
01/30DJNovo Nordisk to Benefit From Dollar Strength in 2015
01/30DJNOVO NORDISK A/S : 4Q Net Profit Beats Estimates
01/30 NOVO NORDISK A/S : Secures FDA OK for Norditropin FlexPro 30 mg/3.0 mL for Patie..
01/29 NOVO NORDISK A/S : New Hydrogen Study Results Reported from Novo Nordisk (Sites ..
01/29 NOVO NORDISK A/S : Gets FDA OK for Norditropin FlexPro 30 mg/3.0 mL for Patients..
01/28 NOVO NORDISK A/S : Studies from Novo Nordisk Provide New Data on Biological and ..
01/28 NOVO NORDISK A/S : New Clinical Trials and Studies Study Findings Recently Were ..
01/28 NOVO NORDISK A/S : TransCelerate BioPharma Welcomes Merck %7E Co. and Novo Nordi..
01/28 NOVO NORDISK A/S : Team Novo Nordisk to compete in Dubai Tour
01/27 NOVO NORDISK A/S : Clinical Trials: More than safety and efficacy
01/23 NOVO NORDISK A/S : receives positive opinion from the European regulatory author..
01/23 NOVO NORDISK A/S : Launches new drug
01/22 Novo Nordisk receives positive opinion from the European regulatory authoriti..
01/22 NOVO NORDISK A/S : Launches Vicotza Diabetes Drug
01/20 NOVO NORDISK A/S : -Switzerland first country to launch Xultophy (IDegLira)
01/20 NOVO NORDISK A/S : Launches diabetes drug in india
01/08 NOVO NORDISK A/S : Patent Issued for Purification of Proteins Using Preparative ..
01/08 NOVO NORDISK A/S : Patent Issued for Seal for a Prefilled Medical Jet Injection ..
01/05 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares
01/04 NOVO NORDISK A/S : Drug may help fight obesity
01/01 NOVO NORDISK A/S : New Protein and Peptide Science Study Findings Recently Were ..
01/01 NOVO NORDISK A/S : Investigators from Novo Nordisk Have Reported New Data on Hor..
01/01 NOVO NORDISK A/S : New Applied Bioinformatics Findings from Novo Nordisk Describ..
2014 NOVO NORDISK A/S : Top Five Sustainability Stories of 2014
2014 Sanofi, Novo Nordisk and Eli Lily Lead the $17 Billion US Modern Insulin Indu..
2014 NOVO NORDISK A/S : Four Seasons Ball raises $119,000
2014 NOVO NORDISK A/S : to promote drug to treat obesity in United States
2014 NOVO NORDISK A/S : receives FDA approval for Saxenda for the treatment of obesit..
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF